These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 33482765)

  • 1. Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Kondo S; Hirakawa H; Ikegami T; Uehara T; Agena S; Uezato J; Kinjyo H; Kise N; Yamashita Y; Tanaka K; Hasegawa N; Kiyuna A; Maeda H; Suzuki M; Gahana A
    BMC Cancer; 2021 Jan; 21(1):87. PubMed ID: 33482765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
    Peraldo-Neia C; Ostano P; Mello-Grand M; Guana F; Gregnanin I; Boschi D; Oliaro-Bosso S; Pippione AC; Carenzo A; De Cecco L; Cavalieri S; Micali A; Perrone F; Averono G; Bagnasacco P; Dosdegani R; Masini L; Krengli M; Aluffi-Valletti P; Valente G; Chiorino G
    Cell Oncol (Dordr); 2021 Apr; 44(2):357-372. PubMed ID: 33211282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact.
    Carpén T; Syrjänen S; Jouhi L; Randen-Brady R; Haglund C; Mäkitie A; Mattila PS; Hagström J
    Cancer Immunol Immunother; 2020 Aug; 69(8):1615-1626. PubMed ID: 32314041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
    Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
    Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma.
    Randén-Brady R; Carpén T; Hautala LC; Tolvanen T; Haglund C; Joenväärä S; Mattila P; Mäkitie A; Lehtonen S; Hagström J; Silén S
    Sci Rep; 2024 Jun; 14(1):14148. PubMed ID: 38898137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.
    Mahal BA; Catalano PJ; Haddad RI; Hanna GJ; Kass JI; Schoenfeld JD; Tishler RB; Margalit DN
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1660-1667. PubMed ID: 31358520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current epidemic of HPV-associated oropharyngeal cancer: An 18-year Danish population-based study with 2,169 patients.
    Zamani M; Grønhøj C; Jensen DH; Carlander AF; Agander T; Kiss K; Olsen C; Baandrup L; Nielsen FC; Andersen E; Friborg J; von Buchwald C
    Eur J Cancer; 2020 Jul; 134():52-59. PubMed ID: 32460181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.
    Kylmä AK; Tolvanen TA; Carpén T; Haglund C; Mäkitie A; Mattila PS; Grenman R; Jouhi L; Sorsa T; Lehtonen S; Hagström J
    Exp Mol Pathol; 2020 Jun; 114():104435. PubMed ID: 32240617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association.
    Biron VL; Côté DW; Seikaly H
    J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S65-9. PubMed ID: 21453664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
    Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
    Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and treatment strategy for HPV-related oropharyngeal cancer.
    Okami K
    Int J Clin Oncol; 2016 Oct; 21(5):827-835. PubMed ID: 27380170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.
    Sewell A; Brown B; Biktasova A; Mills GB; Lu Y; Tyson DR; Issaeva N; Yarbrough WG
    Clin Cancer Res; 2014 May; 20(9):2300-11. PubMed ID: 24599934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, Clinicopathological Characteristics, and Outcome of Human Papillomavirus-Associated Oropharyngeal Cancer in Southern Chinese Patients.
    Lam EW; Chan JY; Chan AB; Ng CS; Lo ST; Lam VS; Chan MM; Ngai CM; Vlantis AC; Ma RK; Chan PK
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):165-73. PubMed ID: 26604268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Molecular Characterization of Surgically Treated Oropharynx Squamous Cell Carcinoma Samples.
    de Carvalho AC; Melendez ME; da Silva Sabato C; Palmero EI; Arantes LMRB; Neto CS; Carvalho AL
    Pathol Oncol Res; 2019 Jul; 25(3):1047-1058. PubMed ID: 30099696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan.
    Hama T; Tokumaru Y; Fujii M; Yane K; Okami K; Kato K; Masuda M; Mineta H; Nakashima T; Sugasawa M; Sakihama N; Yoshizaki T; Hanazawa T; Kato H; Hirano S; Imanishi Y; Kuratomi Y; Otsuki N; Ota I; Sugimoto T; Suzuki S
    Oncology; 2014; 87(3):173-82. PubMed ID: 25033838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.
    Jouhi L; Mohamed H; Mäkitie A; Remes SM; Haglund C; Atula T; Hagström J
    Cancer Immunol Immunother; 2017 Dec; 66(12):1619-1629. PubMed ID: 28856441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.